The American Diabetes Association's annual guidelines for 2018 include new recommendations for use of glucose-lowering drugs with proven cardiovascular benefit in type 2 diabetes, optimization of ...

In early 2020, upon recommendation by leading endocrinologists, American Diabetes Association lowered the target hemoglobin A1C guidelines for children with type 1 diabetes. Their goal in recommending ...

The American Diabetes Association (ADA) released its first position statement that includes detailed guidelines for psychosocial assessments and care based on factors including age, type of diabetes, ...

Type 1 diabetes diagnosis It is critical for us to remember that children are not little adults. Pediatric-onset diabetes is different from adult-onset diabetes due to its distinct epidemiology, ...

The recommendation to limit long periods of sitting comes after multiple studies show how it affects blood glucose management. ADA also gives providers charts to help them understand the cost of ...

For the first time in its annual diabetes management guidelines, the American Diabetes Association (ADA) has aligned its recommendations with those of the American College of Cardiology (ACC) for ...

The ADA published its 2019 Standards of Medical Care in Diabetes, an evidence-based document intended to provide clinicians, patients, and other stakeholders in the diabetes treatment landscape with ...

Diabetic neuropathy is the most common complication of diabetes, yet there’s a lack of targeted treatment options. Distal symmetric polyneuropathy and diabetic autonomic neuropathy are particularly ...

A new version of Medtronic’s advanced, hybrid closed-loop insulin delivery system showed it could help improve blood sugar control throughout the day in adolescents and young adults with Type 1 ...

Important updates of the past year sought to recognize the importance of obesity care and the need to better integrate behavioral health into diabetes care. Guidelines that affect diabetes care come ...

In just the last few years, diabetes technology has grown exponentially smarter. Top of mind now for many devicemakers is the creation of a truly closed-loop system for insulin delivery—a system often ...